nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT2B7—Epirubicin—thyroid cancer	0.198	0.269	CbGbCtD
Fluvastatin—UGT1A1—Sorafenib—thyroid cancer	0.15	0.204	CbGbCtD
Fluvastatin—CYP2B6—Sorafenib—thyroid cancer	0.0579	0.0789	CbGbCtD
Fluvastatin—CYP3A5—Sorafenib—thyroid cancer	0.0456	0.0621	CbGbCtD
Fluvastatin—CYP2C8—Sorafenib—thyroid cancer	0.0438	0.0597	CbGbCtD
Fluvastatin—CYP2C19—Sorafenib—thyroid cancer	0.0368	0.0501	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—thyroid cancer	0.0351	0.0478	CbGbCtD
Fluvastatin—CYP1A2—Sorafenib—thyroid cancer	0.0339	0.0462	CbGbCtD
Fluvastatin—CYP2C9—Sorafenib—thyroid cancer	0.0306	0.0417	CbGbCtD
Fluvastatin—CYP3A4—Vandetanib—thyroid cancer	0.0295	0.0402	CbGbCtD
Fluvastatin—CYP2D6—Sorafenib—thyroid cancer	0.028	0.0381	CbGbCtD
Fluvastatin—CYP3A4—Sorafenib—thyroid cancer	0.0178	0.0242	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—thyroid cancer	0.017	0.0231	CbGbCtD
Fluvastatin—CYP3A4—Doxorubicin—thyroid cancer	0.0108	0.0147	CbGbCtD
Fluvastatin—Pruritus—Vandetanib—thyroid cancer	0.000664	0.00294	CcSEcCtD
Fluvastatin—Myalgia—Sorafenib—thyroid cancer	0.00066	0.00293	CcSEcCtD
Fluvastatin—Arthralgia—Sorafenib—thyroid cancer	0.00066	0.00293	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000656	0.00291	CcSEcCtD
Fluvastatin—Eructation—Epirubicin—thyroid cancer	0.000644	0.00285	CcSEcCtD
Fluvastatin—Diarrhoea—Vandetanib—thyroid cancer	0.000642	0.00284	CcSEcCtD
Fluvastatin—Influenza like illness—Epirubicin—thyroid cancer	0.000637	0.00282	CcSEcCtD
Fluvastatin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000633	0.0028	CcSEcCtD
Fluvastatin—Infection—Sorafenib—thyroid cancer	0.000629	0.00279	CcSEcCtD
Fluvastatin—Shock—Sorafenib—thyroid cancer	0.000623	0.00276	CcSEcCtD
Fluvastatin—Nervous system disorder—Sorafenib—thyroid cancer	0.000621	0.00275	CcSEcCtD
Fluvastatin—Dizziness—Vandetanib—thyroid cancer	0.00062	0.00275	CcSEcCtD
Fluvastatin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00062	0.00275	CcSEcCtD
Fluvastatin—Skin disorder—Sorafenib—thyroid cancer	0.000615	0.00272	CcSEcCtD
Fluvastatin—Anorexia—Sorafenib—thyroid cancer	0.000603	0.00267	CcSEcCtD
Fluvastatin—Vomiting—Vandetanib—thyroid cancer	0.000597	0.00264	CcSEcCtD
Fluvastatin—Eructation—Doxorubicin—thyroid cancer	0.000596	0.00264	CcSEcCtD
Fluvastatin—Rash—Vandetanib—thyroid cancer	0.000592	0.00262	CcSEcCtD
Fluvastatin—Dermatitis—Vandetanib—thyroid cancer	0.000591	0.00262	CcSEcCtD
Fluvastatin—Influenza like illness—Doxorubicin—thyroid cancer	0.000589	0.00261	CcSEcCtD
Fluvastatin—Headache—Vandetanib—thyroid cancer	0.000588	0.0026	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000577	0.00256	CcSEcCtD
Fluvastatin—Abnormal vision—Epirubicin—thyroid cancer	0.000572	0.00253	CcSEcCtD
Fluvastatin—Dyspnoea—Sorafenib—thyroid cancer	0.000564	0.0025	CcSEcCtD
Fluvastatin—Nausea—Vandetanib—thyroid cancer	0.000557	0.00247	CcSEcCtD
Fluvastatin—Dyspepsia—Sorafenib—thyroid cancer	0.000557	0.00247	CcSEcCtD
Fluvastatin—Decreased appetite—Sorafenib—thyroid cancer	0.00055	0.00244	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000546	0.00242	CcSEcCtD
Fluvastatin—Fatigue—Sorafenib—thyroid cancer	0.000546	0.00242	CcSEcCtD
Fluvastatin—Photosensitivity—Epirubicin—thyroid cancer	0.000542	0.0024	CcSEcCtD
Fluvastatin—Constipation—Sorafenib—thyroid cancer	0.000541	0.0024	CcSEcCtD
Fluvastatin—Pain—Sorafenib—thyroid cancer	0.000541	0.0024	CcSEcCtD
Fluvastatin—Vascular purpura—Epirubicin—thyroid cancer	0.000532	0.00236	CcSEcCtD
Fluvastatin—Eczema—Epirubicin—thyroid cancer	0.00053	0.00235	CcSEcCtD
Fluvastatin—Hepatic failure—Epirubicin—thyroid cancer	0.00053	0.00235	CcSEcCtD
Fluvastatin—Abnormal vision—Doxorubicin—thyroid cancer	0.000529	0.00234	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000518	0.00229	CcSEcCtD
Fluvastatin—Renal failure acute—Epirubicin—thyroid cancer	0.000516	0.00228	CcSEcCtD
Fluvastatin—Hot flush—Epirubicin—thyroid cancer	0.000509	0.00225	CcSEcCtD
Fluvastatin—Menopausal symptoms—Epirubicin—thyroid cancer	0.000504	0.00223	CcSEcCtD
Fluvastatin—Urticaria—Sorafenib—thyroid cancer	0.000503	0.00223	CcSEcCtD
Fluvastatin—Photosensitivity—Doxorubicin—thyroid cancer	0.000502	0.00222	CcSEcCtD
Fluvastatin—Abdominal pain—Sorafenib—thyroid cancer	0.0005	0.00222	CcSEcCtD
Fluvastatin—Body temperature increased—Sorafenib—thyroid cancer	0.0005	0.00222	CcSEcCtD
Fluvastatin—Dermatitis bullous—Epirubicin—thyroid cancer	0.000498	0.00221	CcSEcCtD
Fluvastatin—Purpura—Epirubicin—thyroid cancer	0.000494	0.00219	CcSEcCtD
Fluvastatin—Vascular purpura—Doxorubicin—thyroid cancer	0.000492	0.00218	CcSEcCtD
Fluvastatin—Eczema—Doxorubicin—thyroid cancer	0.00049	0.00217	CcSEcCtD
Fluvastatin—Hepatic failure—Doxorubicin—thyroid cancer	0.00049	0.00217	CcSEcCtD
Fluvastatin—Renal failure acute—Doxorubicin—thyroid cancer	0.000477	0.00211	CcSEcCtD
Fluvastatin—Pain in extremity—Epirubicin—thyroid cancer	0.000476	0.00211	CcSEcCtD
Fluvastatin—Osteoarthritis—Epirubicin—thyroid cancer	0.000476	0.00211	CcSEcCtD
Fluvastatin—Hot flush—Doxorubicin—thyroid cancer	0.000471	0.00209	CcSEcCtD
Fluvastatin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000467	0.00207	CcSEcCtD
Fluvastatin—Hypersensitivity—Sorafenib—thyroid cancer	0.000466	0.00207	CcSEcCtD
Fluvastatin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000461	0.00204	CcSEcCtD
Fluvastatin—Face oedema—Epirubicin—thyroid cancer	0.000459	0.00204	CcSEcCtD
Fluvastatin—Purpura—Doxorubicin—thyroid cancer	0.000457	0.00202	CcSEcCtD
Fluvastatin—Asthenia—Sorafenib—thyroid cancer	0.000454	0.00201	CcSEcCtD
Fluvastatin—Pruritus—Sorafenib—thyroid cancer	0.000448	0.00198	CcSEcCtD
Fluvastatin—Pain in extremity—Doxorubicin—thyroid cancer	0.00044	0.00195	CcSEcCtD
Fluvastatin—Osteoarthritis—Doxorubicin—thyroid cancer	0.00044	0.00195	CcSEcCtD
Fluvastatin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000435	0.00193	CcSEcCtD
Fluvastatin—Diarrhoea—Sorafenib—thyroid cancer	0.000433	0.00192	CcSEcCtD
Fluvastatin—Breast disorder—Epirubicin—thyroid cancer	0.00043	0.00191	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000429	0.0019	CcSEcCtD
Fluvastatin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000426	0.00189	CcSEcCtD
Fluvastatin—Face oedema—Doxorubicin—thyroid cancer	0.000425	0.00188	CcSEcCtD
Fluvastatin—Gastritis—Epirubicin—thyroid cancer	0.000421	0.00187	CcSEcCtD
Fluvastatin—Muscular weakness—Epirubicin—thyroid cancer	0.00042	0.00186	CcSEcCtD
Fluvastatin—Dizziness—Sorafenib—thyroid cancer	0.000419	0.00185	CcSEcCtD
Fluvastatin—Influenza—Epirubicin—thyroid cancer	0.000411	0.00182	CcSEcCtD
Fluvastatin—Eosinophilia—Epirubicin—thyroid cancer	0.000407	0.0018	CcSEcCtD
Fluvastatin—Pancreatitis—Epirubicin—thyroid cancer	0.000403	0.00179	CcSEcCtD
Fluvastatin—Vomiting—Sorafenib—thyroid cancer	0.000402	0.00178	CcSEcCtD
Fluvastatin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000402	0.00178	CcSEcCtD
Fluvastatin—Rash—Sorafenib—thyroid cancer	0.000399	0.00177	CcSEcCtD
Fluvastatin—Dermatitis—Sorafenib—thyroid cancer	0.000399	0.00177	CcSEcCtD
Fluvastatin—Breast disorder—Doxorubicin—thyroid cancer	0.000398	0.00176	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000397	0.00176	CcSEcCtD
Fluvastatin—Headache—Sorafenib—thyroid cancer	0.000397	0.00176	CcSEcCtD
Fluvastatin—Bronchitis—Epirubicin—thyroid cancer	0.000396	0.00175	CcSEcCtD
Fluvastatin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000394	0.00174	CcSEcCtD
Fluvastatin—Gastritis—Doxorubicin—thyroid cancer	0.00039	0.00173	CcSEcCtD
Fluvastatin—Muscular weakness—Doxorubicin—thyroid cancer	0.000388	0.00172	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000382	0.00169	CcSEcCtD
Fluvastatin—Influenza—Doxorubicin—thyroid cancer	0.000381	0.00169	CcSEcCtD
Fluvastatin—Eosinophilia—Doxorubicin—thyroid cancer	0.000377	0.00167	CcSEcCtD
Fluvastatin—Nausea—Sorafenib—thyroid cancer	0.000376	0.00167	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000375	0.00166	CcSEcCtD
Fluvastatin—Pancreatitis—Doxorubicin—thyroid cancer	0.000373	0.00165	CcSEcCtD
Fluvastatin—Infestation NOS—Epirubicin—thyroid cancer	0.000367	0.00163	CcSEcCtD
Fluvastatin—Infestation—Epirubicin—thyroid cancer	0.000367	0.00163	CcSEcCtD
Fluvastatin—Bronchitis—Doxorubicin—thyroid cancer	0.000366	0.00162	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000364	0.00161	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00036	0.00159	CcSEcCtD
Fluvastatin—Conjunctivitis—Epirubicin—thyroid cancer	0.000357	0.00158	CcSEcCtD
Fluvastatin—Urinary tract infection—Epirubicin—thyroid cancer	0.000357	0.00158	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000354	0.00157	CcSEcCtD
Fluvastatin—Sweating—Epirubicin—thyroid cancer	0.000352	0.00156	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000347	0.00154	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000347	0.00154	CcSEcCtD
Fluvastatin—Sinusitis—Epirubicin—thyroid cancer	0.000344	0.00152	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—thyroid cancer	0.000339	0.0015	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—thyroid cancer	0.000339	0.0015	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000336	0.00149	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000333	0.00147	CcSEcCtD
Fluvastatin—Rhinitis—Epirubicin—thyroid cancer	0.00033	0.00146	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—thyroid cancer	0.00033	0.00146	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—thyroid cancer	0.00033	0.00146	CcSEcCtD
Fluvastatin—Hepatitis—Epirubicin—thyroid cancer	0.000329	0.00146	CcSEcCtD
Fluvastatin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000328	0.00145	CcSEcCtD
Fluvastatin—Pharyngitis—Epirubicin—thyroid cancer	0.000327	0.00145	CcSEcCtD
Fluvastatin—Sweating—Doxorubicin—thyroid cancer	0.000325	0.00144	CcSEcCtD
Fluvastatin—Oedema peripheral—Epirubicin—thyroid cancer	0.000324	0.00144	CcSEcCtD
Fluvastatin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000324	0.00143	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000321	0.00142	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—thyroid cancer	0.000318	0.00141	CcSEcCtD
Fluvastatin—Visual impairment—Epirubicin—thyroid cancer	0.000317	0.00141	CcSEcCtD
Fluvastatin—Erythema multiforme—Epirubicin—thyroid cancer	0.000311	0.00138	CcSEcCtD
Fluvastatin—Flushing—Epirubicin—thyroid cancer	0.000306	0.00135	CcSEcCtD
Fluvastatin—Cardiac disorder—Epirubicin—thyroid cancer	0.000306	0.00135	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—thyroid cancer	0.000305	0.00135	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—thyroid cancer	0.000305	0.00135	CcSEcCtD
Fluvastatin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000303	0.00134	CcSEcCtD
Fluvastatin—Pharyngitis—Doxorubicin—thyroid cancer	0.000302	0.00134	CcSEcCtD
Fluvastatin—Oedema peripheral—Doxorubicin—thyroid cancer	0.0003	0.00133	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000299	0.00133	CcSEcCtD
Fluvastatin—Angiopathy—Epirubicin—thyroid cancer	0.000299	0.00132	CcSEcCtD
Fluvastatin—Immune system disorder—Epirubicin—thyroid cancer	0.000297	0.00132	CcSEcCtD
Fluvastatin—Chills—Epirubicin—thyroid cancer	0.000295	0.00131	CcSEcCtD
Fluvastatin—Arrhythmia—Epirubicin—thyroid cancer	0.000294	0.0013	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—thyroid cancer	0.000294	0.0013	CcSEcCtD
Fluvastatin—Alopecia—Epirubicin—thyroid cancer	0.000291	0.00129	CcSEcCtD
Fluvastatin—Mental disorder—Epirubicin—thyroid cancer	0.000288	0.00128	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000288	0.00128	CcSEcCtD
Fluvastatin—Erythema—Epirubicin—thyroid cancer	0.000287	0.00127	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—thyroid cancer	0.000283	0.00125	CcSEcCtD
Fluvastatin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000283	0.00125	CcSEcCtD
Fluvastatin—Flatulence—Epirubicin—thyroid cancer	0.000282	0.00125	CcSEcCtD
Fluvastatin—Dysgeusia—Epirubicin—thyroid cancer	0.000281	0.00124	CcSEcCtD
Fluvastatin—Back pain—Epirubicin—thyroid cancer	0.000277	0.00123	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—thyroid cancer	0.000276	0.00122	CcSEcCtD
Fluvastatin—Muscle spasms—Epirubicin—thyroid cancer	0.000276	0.00122	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—thyroid cancer	0.000275	0.00122	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—thyroid cancer	0.000273	0.00121	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—thyroid cancer	0.000272	0.00121	CcSEcCtD
Fluvastatin—Alopecia—Doxorubicin—thyroid cancer	0.000269	0.00119	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—thyroid cancer	0.000267	0.00118	CcSEcCtD
Fluvastatin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000266	0.00118	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—thyroid cancer	0.000265	0.00118	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—thyroid cancer	0.000261	0.00116	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—thyroid cancer	0.00026	0.00115	CcSEcCtD
Fluvastatin—Malaise—Epirubicin—thyroid cancer	0.000258	0.00115	CcSEcCtD
Fluvastatin—Vertigo—Epirubicin—thyroid cancer	0.000258	0.00114	CcSEcCtD
Fluvastatin—Syncope—Epirubicin—thyroid cancer	0.000257	0.00114	CcSEcCtD
Fluvastatin—Leukopenia—Epirubicin—thyroid cancer	0.000257	0.00114	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—thyroid cancer	0.000257	0.00114	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—thyroid cancer	0.000255	0.00113	CcSEcCtD
Fluvastatin—Loss of consciousness—Epirubicin—thyroid cancer	0.000252	0.00112	CcSEcCtD
Fluvastatin—Cough—Epirubicin—thyroid cancer	0.00025	0.00111	CcSEcCtD
Fluvastatin—Hypertension—Epirubicin—thyroid cancer	0.000247	0.0011	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000246	0.00109	CcSEcCtD
Fluvastatin—Arthralgia—Epirubicin—thyroid cancer	0.000244	0.00108	CcSEcCtD
Fluvastatin—Myalgia—Epirubicin—thyroid cancer	0.000244	0.00108	CcSEcCtD
Fluvastatin—Chest pain—Epirubicin—thyroid cancer	0.000244	0.00108	CcSEcCtD
Fluvastatin—Anxiety—Epirubicin—thyroid cancer	0.000243	0.00108	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000242	0.00107	CcSEcCtD
Fluvastatin—Discomfort—Epirubicin—thyroid cancer	0.000241	0.00107	CcSEcCtD
Fluvastatin—Malaise—Doxorubicin—thyroid cancer	0.000239	0.00106	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—thyroid cancer	0.000238	0.00106	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—thyroid cancer	0.000238	0.00105	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—thyroid cancer	0.000237	0.00105	CcSEcCtD
Fluvastatin—Confusional state—Epirubicin—thyroid cancer	0.000236	0.00105	CcSEcCtD
Fluvastatin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000234	0.00104	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000233	0.00103	CcSEcCtD
Fluvastatin—Infection—Epirubicin—thyroid cancer	0.000232	0.00103	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—thyroid cancer	0.000231	0.00103	CcSEcCtD
Fluvastatin—Shock—Epirubicin—thyroid cancer	0.00023	0.00102	CcSEcCtD
Fluvastatin—Nervous system disorder—Epirubicin—thyroid cancer	0.000229	0.00102	CcSEcCtD
Fluvastatin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000229	0.00101	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—thyroid cancer	0.000229	0.00101	CcSEcCtD
Fluvastatin—Skin disorder—Epirubicin—thyroid cancer	0.000227	0.00101	CcSEcCtD
Fluvastatin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000226	0.001	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—thyroid cancer	0.000226	0.001	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—thyroid cancer	0.000226	0.001	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—thyroid cancer	0.000226	0.001	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—thyroid cancer	0.000225	0.000997	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000224	0.000994	CcSEcCtD
Fluvastatin—Discomfort—Doxorubicin—thyroid cancer	0.000223	0.000988	CcSEcCtD
Fluvastatin—Anorexia—Epirubicin—thyroid cancer	0.000223	0.000988	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—thyroid cancer	0.000218	0.000967	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000216	0.000959	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—thyroid cancer	0.000215	0.000953	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000213	0.000944	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—thyroid cancer	0.000213	0.000944	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000212	0.00094	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000212	0.000939	CcSEcCtD
Fluvastatin—Insomnia—Epirubicin—thyroid cancer	0.000212	0.000937	CcSEcCtD
Fluvastatin—Skin disorder—Doxorubicin—thyroid cancer	0.00021	0.000932	CcSEcCtD
Fluvastatin—Paraesthesia—Epirubicin—thyroid cancer	0.00021	0.000931	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000209	0.000927	CcSEcCtD
Fluvastatin—Dyspnoea—Epirubicin—thyroid cancer	0.000209	0.000924	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—thyroid cancer	0.000206	0.000914	CcSEcCtD
Fluvastatin—Dyspepsia—Epirubicin—thyroid cancer	0.000206	0.000912	CcSEcCtD
Fluvastatin—Decreased appetite—Epirubicin—thyroid cancer	0.000203	0.000901	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000202	0.000895	CcSEcCtD
Fluvastatin—Fatigue—Epirubicin—thyroid cancer	0.000202	0.000894	CcSEcCtD
Fluvastatin—Pain—Epirubicin—thyroid cancer	0.0002	0.000886	CcSEcCtD
Fluvastatin—Constipation—Epirubicin—thyroid cancer	0.0002	0.000886	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000197	0.000874	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—thyroid cancer	0.000196	0.000867	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—thyroid cancer	0.000194	0.000861	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—thyroid cancer	0.000193	0.000855	CcSEcCtD
Fluvastatin—Feeling abnormal—Epirubicin—thyroid cancer	0.000193	0.000854	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000191	0.000848	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—thyroid cancer	0.000191	0.000844	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—thyroid cancer	0.000188	0.000834	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000187	0.000828	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—thyroid cancer	0.000187	0.000827	CcSEcCtD
Fluvastatin—Urticaria—Epirubicin—thyroid cancer	0.000186	0.000823	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—thyroid cancer	0.000185	0.00082	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—thyroid cancer	0.000185	0.00082	CcSEcCtD
Fluvastatin—Body temperature increased—Epirubicin—thyroid cancer	0.000185	0.000819	CcSEcCtD
Fluvastatin—Abdominal pain—Epirubicin—thyroid cancer	0.000185	0.000819	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000178	0.00079	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000177	0.000784	CcSEcCtD
Fluvastatin—Hypersensitivity—Epirubicin—thyroid cancer	0.000172	0.000764	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—thyroid cancer	0.000172	0.000762	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—thyroid cancer	0.000171	0.000758	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—thyroid cancer	0.000171	0.000758	CcSEcCtD
Fluvastatin—Asthenia—Epirubicin—thyroid cancer	0.000168	0.000744	CcSEcCtD
Fluvastatin—Pruritus—Epirubicin—thyroid cancer	0.000165	0.000733	CcSEcCtD
Fluvastatin—Diarrhoea—Epirubicin—thyroid cancer	0.00016	0.000709	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000159	0.000707	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—thyroid cancer	0.000155	0.000688	CcSEcCtD
Fluvastatin—Dizziness—Epirubicin—thyroid cancer	0.000155	0.000685	CcSEcCtD
Fluvastatin—Pruritus—Doxorubicin—thyroid cancer	0.000153	0.000679	CcSEcCtD
Fluvastatin—Vomiting—Epirubicin—thyroid cancer	0.000149	0.000659	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—thyroid cancer	0.000148	0.000656	CcSEcCtD
Fluvastatin—Rash—Epirubicin—thyroid cancer	0.000147	0.000654	CcSEcCtD
Fluvastatin—Dermatitis—Epirubicin—thyroid cancer	0.000147	0.000653	CcSEcCtD
Fluvastatin—Headache—Epirubicin—thyroid cancer	0.000147	0.000649	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—thyroid cancer	0.000143	0.000634	CcSEcCtD
Fluvastatin—Nausea—Epirubicin—thyroid cancer	0.000139	0.000616	CcSEcCtD
Fluvastatin—Vomiting—Doxorubicin—thyroid cancer	0.000138	0.00061	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—thyroid cancer	0.000136	0.000605	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—thyroid cancer	0.000136	0.000604	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—thyroid cancer	0.000136	0.000601	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—thyroid cancer	0.000129	0.00057	CcSEcCtD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000105	0.0026	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—NDUFA13—thyroid cancer	0.000104	0.00258	CbGpPWpGaD
Fluvastatin—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000104	0.00257	CbGpPWpGaD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000103	0.00255	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—MINPP1—thyroid cancer	9.97e-05	0.00247	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CHST14—thyroid cancer	9.81e-05	0.00243	CbGpPWpGaD
Fluvastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.54e-05	0.00236	CbGpPWpGaD
Fluvastatin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.36e-05	0.00231	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—HPGD—thyroid cancer	9.3e-05	0.0023	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.25e-05	0.00229	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—MINPP1—thyroid cancer	9.14e-05	0.00226	CbGpPWpGaD
Fluvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	8.91e-05	0.0022	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	8.89e-05	0.0022	CbGpPWpGaD
Fluvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	8.86e-05	0.00219	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—HPGD—thyroid cancer	8.76e-05	0.00217	CbGpPWpGaD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.65e-05	0.00214	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	8.65e-05	0.00214	CbGpPWpGaD
Fluvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.51e-05	0.0021	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—NDUFA13—thyroid cancer	8.48e-05	0.0021	CbGpPWpGaD
Fluvastatin—CYP2B6—Biological oxidations—RXRA—thyroid cancer	8.44e-05	0.00209	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.29e-05	0.00205	CbGpPWpGaD
Fluvastatin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	8.25e-05	0.00204	CbGpPWpGaD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.04e-05	0.00199	CbGpPWpGaD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8e-05	0.00198	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CHST14—thyroid cancer	7.97e-05	0.00197	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—HPGD—thyroid cancer	7.91e-05	0.00196	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	7.9e-05	0.00195	CbGpPWpGaD
Fluvastatin—CYP1A1—Biological oxidations—RXRA—thyroid cancer	7.79e-05	0.00193	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	7.77e-05	0.00192	CbGpPWpGaD
Fluvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.76e-05	0.00192	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.6e-05	0.00188	CbGpPWpGaD
Fluvastatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	7.52e-05	0.00186	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	7.45e-05	0.00184	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CHST14—thyroid cancer	7.3e-05	0.00181	CbGpPWpGaD
Fluvastatin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.22e-05	0.00179	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.22e-05	0.00179	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	7.22e-05	0.00179	CbGpPWpGaD
Fluvastatin—CYP2C8—Biological oxidations—RXRA—thyroid cancer	7.15e-05	0.00177	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.11e-05	0.00176	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.1e-05	0.00176	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	7.09e-05	0.00175	CbGpPWpGaD
Fluvastatin—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	7.04e-05	0.00174	CbGpPWpGaD
Fluvastatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	6.89e-05	0.0017	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.78e-05	0.00168	CbGpPWpGaD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.76e-05	0.00167	CbGpPWpGaD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.72e-05	0.00166	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	6.67e-05	0.00165	CbGpPWpGaD
Fluvastatin—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.63e-05	0.00164	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—TPR—thyroid cancer	6.55e-05	0.00162	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PRKAR1A—thyroid cancer	6.45e-05	0.00159	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—HPGD—thyroid cancer	6.42e-05	0.00159	CbGpPWpGaD
Fluvastatin—CYP2C19—Biological oxidations—RXRA—thyroid cancer	6.38e-05	0.00158	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	6.33e-05	0.00157	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—MINPP1—thyroid cancer	6.2e-05	0.00153	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.18e-05	0.00153	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—MINPP1—thyroid cancer	6.06e-05	0.0015	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—HPGD—thyroid cancer	5.89e-05	0.00146	CbGpPWpGaD
Fluvastatin—CYP2D6—Biological oxidations—RXRA—thyroid cancer	5.87e-05	0.00145	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.84e-05	0.00144	CbGpPWpGaD
Fluvastatin—CYP2C9—Biological oxidations—RXRA—thyroid cancer	5.82e-05	0.00144	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—MINPP1—thyroid cancer	5.73e-05	0.00142	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	5.52e-05	0.00136	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.4e-05	0.00134	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—TPR—thyroid cancer	5.34e-05	0.00132	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.28e-05	0.00131	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—NDUFA13—thyroid cancer	5.27e-05	0.0013	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PRKAR1A—thyroid cancer	5.25e-05	0.0013	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—MINPP1—thyroid cancer	5.25e-05	0.0013	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	5.15e-05	0.00127	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—TPR—thyroid cancer	5.03e-05	0.00124	CbGpPWpGaD
Fluvastatin—CYP1A2—Biological oxidations—RXRA—thyroid cancer	4.97e-05	0.00123	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CHST14—thyroid cancer	4.96e-05	0.00123	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	4.95e-05	0.00122	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—SLC5A5—thyroid cancer	4.9e-05	0.00121	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—NDUFA13—thyroid cancer	4.87e-05	0.0012	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CHST14—thyroid cancer	4.85e-05	0.0012	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.78e-05	0.00118	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	4.75e-05	0.00117	CbGpPWpGaD
Fluvastatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	4.75e-05	0.00117	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.69e-05	0.00116	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.6e-05	0.00114	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CHST14—thyroid cancer	4.58e-05	0.00113	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—TPR—thyroid cancer	4.54e-05	0.00112	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.54e-05	0.00112	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.49e-05	0.00111	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	4.47e-05	0.0011	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.46e-05	0.0011	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—MINPP1—thyroid cancer	4.31e-05	0.00107	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.27e-05	0.00106	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CHST14—thyroid cancer	4.2e-05	0.00104	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—RXRA—thyroid cancer	4.12e-05	0.00102	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	4.04e-05	0.000998	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.01e-05	0.000991	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—SLC5A5—thyroid cancer	4e-05	0.000989	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—HPGD—thyroid cancer	4e-05	0.000988	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.98e-05	0.000985	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—HPGD—thyroid cancer	3.91e-05	0.000966	CbGpPWpGaD
Fluvastatin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.84e-05	0.000948	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	3.77e-05	0.000932	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CHST14—thyroid cancer	3.75e-05	0.000926	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—TPR—thyroid cancer	3.69e-05	0.000912	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—HPGD—thyroid cancer	3.69e-05	0.000912	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.66e-05	0.000906	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—MINPP1—thyroid cancer	3.65e-05	0.000903	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.63e-05	0.000898	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	3.63e-05	0.000898	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.53e-05	0.000873	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CHST14—thyroid cancer	3.45e-05	0.000852	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CHST14—thyroid cancer	3.42e-05	0.000845	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—SLC5A5—thyroid cancer	3.4e-05	0.000841	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—HPGD—thyroid cancer	3.38e-05	0.000837	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—TPR—thyroid cancer	3.38e-05	0.000836	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—RXRA—thyroid cancer	3.36e-05	0.000831	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	3.33e-05	0.000823	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—RXRA—thyroid cancer	3.17e-05	0.000783	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.1e-05	0.000768	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.08e-05	0.000761	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—HPGD—thyroid cancer	3.02e-05	0.000747	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.02e-05	0.000746	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.99e-05	0.00074	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CHST14—thyroid cancer	2.92e-05	0.000722	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—RXRA—thyroid cancer	2.86e-05	0.000706	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.82e-05	0.000697	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—HPGD—thyroid cancer	2.78e-05	0.000687	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—SLC5A5—thyroid cancer	2.76e-05	0.000683	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—HPGD—thyroid cancer	2.75e-05	0.000681	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.74e-05	0.000679	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PPARG—thyroid cancer	2.6e-05	0.000643	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	2.53e-05	0.000626	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.45e-05	0.000606	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.4e-05	0.000592	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.37e-05	0.000587	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—HPGD—thyroid cancer	2.35e-05	0.000582	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—RXRA—thyroid cancer	2.32e-05	0.000574	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—TPR—thyroid cancer	2.3e-05	0.000568	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	2.26e-05	0.000558	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CHST14—thyroid cancer	2.25e-05	0.000557	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—TPR—thyroid cancer	2.24e-05	0.000555	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.23e-05	0.000552	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.21e-05	0.000546	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.13e-05	0.000526	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PPARG—thyroid cancer	2.12e-05	0.000524	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—TPR—thyroid cancer	2.12e-05	0.000524	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	2.08e-05	0.000516	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.07e-05	0.000511	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PTGS2—thyroid cancer	2.05e-05	0.000506	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PPARG—thyroid cancer	2e-05	0.000494	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—TPR—thyroid cancer	1.94e-05	0.00048	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.91e-05	0.000473	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.91e-05	0.000472	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.89e-05	0.000467	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—HPGD—thyroid cancer	1.82e-05	0.000449	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PPARG—thyroid cancer	1.8e-05	0.000446	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PTEN—thyroid cancer	1.78e-05	0.000441	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—TPR—thyroid cancer	1.73e-05	0.000429	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.73e-05	0.000428	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.72e-05	0.000425	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.71e-05	0.000422	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.68e-05	0.000415	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PTGS2—thyroid cancer	1.67e-05	0.000413	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—TPR—thyroid cancer	1.6e-05	0.000394	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.59e-05	0.000392	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—TPR—thyroid cancer	1.58e-05	0.000391	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTGS2—thyroid cancer	1.57e-05	0.000389	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.57e-05	0.000388	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.56e-05	0.000385	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.55e-05	0.000382	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.49e-05	0.000368	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PPARG—thyroid cancer	1.47e-05	0.000362	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PTEN—thyroid cancer	1.45e-05	0.00036	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.45e-05	0.00036	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—RXRA—thyroid cancer	1.44e-05	0.000357	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTGS2—thyroid cancer	1.42e-05	0.000351	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—RXRA—thyroid cancer	1.41e-05	0.000349	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.41e-05	0.000349	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.37e-05	0.000339	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.36e-05	0.000337	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—TPR—thyroid cancer	1.35e-05	0.000334	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.34e-05	0.000332	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—RXRA—thyroid cancer	1.33e-05	0.00033	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.33e-05	0.000329	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.3e-05	0.000321	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.3e-05	0.000321	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTEN—thyroid cancer	1.24e-05	0.000306	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—RXRA—thyroid cancer	1.22e-05	0.000302	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.22e-05	0.000301	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.2e-05	0.000298	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.19e-05	0.000295	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.19e-05	0.000294	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.18e-05	0.000293	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.15e-05	0.000285	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.11e-05	0.000274	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—RXRA—thyroid cancer	1.09e-05	0.00027	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.06e-05	0.000262	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.06e-05	0.000261	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—TPR—thyroid cancer	1.04e-05	0.000258	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—AKT1—thyroid cancer	1.03e-05	0.000254	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.03e-05	0.000254	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.01e-05	0.00025	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTEN—thyroid cancer	1.01e-05	0.000249	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—RXRA—thyroid cancer	1e-05	0.000248	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—RXRA—thyroid cancer	9.95e-06	0.000246	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.67e-06	0.000239	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.48e-06	0.000234	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTEN—thyroid cancer	9.21e-06	0.000228	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PPARG—thyroid cancer	9.11e-06	0.000225	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PPARG—thyroid cancer	8.91e-06	0.00022	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—RXRA—thyroid cancer	8.5e-06	0.00021	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PPARG—thyroid cancer	8.42e-06	0.000208	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—AKT1—thyroid cancer	8.38e-06	0.000207	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.27e-06	0.000204	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—AKT1—thyroid cancer	7.9e-06	0.000195	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.81e-06	0.000193	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PPARG—thyroid cancer	7.72e-06	0.000191	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTGS2—thyroid cancer	7.17e-06	0.000177	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—AKT1—thyroid cancer	7.13e-06	0.000176	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTGS2—thyroid cancer	7.01e-06	0.000173	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PPARG—thyroid cancer	6.89e-06	0.00017	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTGS2—thyroid cancer	6.62e-06	0.000164	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—RXRA—thyroid cancer	6.56e-06	0.000162	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PPARG—thyroid cancer	6.33e-06	0.000157	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PPARG—thyroid cancer	6.28e-06	0.000155	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTEN—thyroid cancer	6.25e-06	0.000155	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTEN—thyroid cancer	6.11e-06	0.000151	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTGS2—thyroid cancer	6.07e-06	0.00015	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—AKT1—thyroid cancer	5.79e-06	0.000143	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTEN—thyroid cancer	5.77e-06	0.000143	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.42e-06	0.000134	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PPARG—thyroid cancer	5.37e-06	0.000133	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—AKT1—thyroid cancer	5.31e-06	0.000131	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTEN—thyroid cancer	5.29e-06	0.000131	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.98e-06	0.000123	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.94e-06	0.000122	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTEN—thyroid cancer	4.72e-06	0.000117	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTEN—thyroid cancer	4.35e-06	0.000107	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTEN—thyroid cancer	4.31e-06	0.000107	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTGS2—thyroid cancer	4.22e-06	0.000104	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PPARG—thyroid cancer	4.14e-06	0.000102	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTEN—thyroid cancer	3.68e-06	9.1e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—AKT1—thyroid cancer	3.6e-06	8.91e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—AKT1—thyroid cancer	3.52e-06	8.71e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—AKT1—thyroid cancer	3.33e-06	8.23e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.26e-06	8.06e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—AKT1—thyroid cancer	3.05e-06	7.54e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTEN—thyroid cancer	2.84e-06	7.03e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—AKT1—thyroid cancer	2.72e-06	6.73e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—AKT1—thyroid cancer	2.5e-06	6.19e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—AKT1—thyroid cancer	2.48e-06	6.14e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—AKT1—thyroid cancer	2.12e-06	5.25e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—AKT1—thyroid cancer	1.64e-06	4.05e-05	CbGpPWpGaD
